These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 33444084)

  • 1. Potential role of glycoprotein 340 in milder SARS-CoV-2 infection in children.
    Zarei M; Bose D; Ali Akbari Ghavimi S; Nouri-Vaskeh M; Mohammadi M; Sahebkar A
    Expert Rev Anti Infect Ther; 2021 Jun; 19(6):675-677. PubMed ID: 33444084
    [No Abstract]   [Full Text] [Related]  

  • 2. Aging and monocyte immunometabolism in COVID-19.
    Pence BD
    Aging (Albany NY); 2021 Mar; 13(7):9154-9155. PubMed ID: 33795524
    [No Abstract]   [Full Text] [Related]  

  • 3. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
    Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
    Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 is milder in children possibly due to cross-immunity.
    Devulapalli CS
    Acta Paediatr; 2020 Nov; 109(11):2422. PubMed ID: 32521068
    [No Abstract]   [Full Text] [Related]  

  • 7. In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans.
    Choudhury A; Das NC; Patra R; Mukherjee S
    J Med Virol; 2021 Apr; 93(4):2476-2486. PubMed ID: 33404091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
    Bouayad A
    Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMPRSS2 activity may mediate sex differences in COVID-19 severity.
    Okwan-Duodu D; Lim EC; You S; Engman DM
    Signal Transduct Target Ther; 2021 Mar; 6(1):100. PubMed ID: 33649313
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term clinical and serological follow-up of paediatric patients infected by SARS-CoV-2.
    Calitri C; Fantone F; Benetti S; Lupica MM; Ignaccolo MG; Banino E; Viano A; Pace M; Castella A; Gaido F; Garofalo F; AslTorinoTre Study Group Paediatric Covid
    Infez Med; 2021 Jun; 29(2):216-223. PubMed ID: 34061786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
    Li G; Wang A; Chen Y; Sun Y; Du Y; Wang X; Ding P; Jia R; Wang Y; Zhang G
    Front Immunol; 2021; 12():635677. PubMed ID: 33777026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals.
    Stanczak MA; Sanin DE; Apostolova P; Nerz G; Lampaki D; Hofmann M; Steinmann D; Krohn-Grimberghe M; Thimme R; Mittler G; Waller CF; Pearce EJ; Pearce EL
    Nat Commun; 2021 Apr; 12(1):2133. PubMed ID: 33837219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
    Speer G; Somogyi P
    Endocr J; 2021 Feb; 68(2):129-136. PubMed ID: 33473054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
    Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S
    Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.
    Idrees D; Kumar V
    Biochem Biophys Res Commun; 2021 May; 554():94-98. PubMed ID: 33789211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is COVID-19 a hyperferritinemic syndrome in children?
    Giannattasio A; D'Anna C; Muzzica S; Mauro A; Rosa M; Angrisani F; Acierno S; Savoia F; Tipo V
    Clin Chem Lab Med; 2021 Oct; 59(11):e409-e412. PubMed ID: 34013681
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-body antibodies in COVID-19.
    Lichtman AH
    Sci Immunol; 2021 Jun; 6(60):. PubMed ID: 34088747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaesthesia-related drugs and SARS-CoV-2 infection.
    Hirota K; Lambert DG
    Br J Anaesth; 2021 Jul; 127(1):e32-e34. PubMed ID: 33934887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.